Ibrahim AlZaim
Overview
Explore the profile of Ibrahim AlZaim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Fakih W, Zeitoun R, AlZaim I, Eid A, Kobeissy F, Abd-Elrahman K, et al.
Obesity (Silver Spring)
. 2022 Apr;
30(5):982-993.
PMID: 35470973
The metabolic syndrome comprises a family of clinical and laboratory findings, including insulin resistance, hyperglycemia, hypertriglyceridemia, low high-density lipoprotein cholesterol levels, and hypertension, in addition to central obesity. The syndrome...
12.
AlZaim I, Al-Saidi A, Hammoud S, Darwiche N, Al-Dhaheri Y, Eid A, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406450
The increased global prevalence of metabolic disorders including obesity, insulin resistance, metabolic syndrome and diabetes is mirrored by an increased incidence of prostate cancer (PCa). Ample evidence suggests that these...
13.
Dwaib H, Ajouz G, AlZaim I, Rafeh R, Mroueh A, Mougharbil N, et al.
J Am Heart Assoc
. 2021 Dec;
10(24):e023227.
PMID: 34873915
Background The complexity of the interaction between metabolic dysfunction and cardiovascular complications has long been recognized to extend beyond simple perturbations of blood glucose levels. Yet, structured interventions targeting the...
14.
Dwaib H, AlZaim I, Ajouz G, Eid A, El-Yazbi A
Mol Pharmacol
. 2021 Nov;
102(1):481-500.
PMID: 34732528
The evolving view of gut microbiota has shifted toward describing the colonic flora as a dynamic organ in continuous interaction with systemic physiologic processes. Alterations of the normal gut bacterial...
15.
Hatem G, Ghanem D, Kellen E, AlZaim I, Goossens M
Cancer Control
. 2021 Oct;
28:10732748211053149.
PMID: 34706582
Background: Lebanon has an increasing cancer burden. Sufficient knowledge of cancer risk factors and early cancer symptoms can help lower cancer burden by facilitating primary prevention and early diagnosis. This...
16.
Hammoud S, AlZaim I, Al-Dhaheri Y, Eid A, El-Yazbi A
Front Endocrinol (Lausanne)
. 2021 Aug;
12:707126.
PMID: 34408726
A healthy adipose tissue (AT) is indispensable to human wellbeing. Among other roles, it contributes to energy homeostasis and provides insulation for internal organs. Adipocytes were previously thought to be...
17.
Chaaban I, Hafez H, AlZaim I, Tannous C, Ragab H, Hazzaa A, et al.
Bioorg Chem
. 2021 Jun;
113:105035.
PMID: 34091287
We managed to repurpose the old drug iodoquinol to a series of novel anticancer 7-iodo-quinoline-5,8-diones. Twelve compounds were identified as inhibitors of moderate to high potency on an inhouse MCF-7...
18.
Dwaib H, AlZaim I, Eid A, Obeid O, El-Yazbi A
Front Pharmacol
. 2021 Apr;
12:626313.
PMID: 33897419
Cardiometabolic syndrome (CMS) is a cluster of maladaptive cardiovascular, renal, thrombotic, inflammatory, and metabolic disorders. It confers a high risk of cardiovascular mortality and morbidity. CMS is triggered by major...
19.
Alaaeddine R, AlZaim I, Hammoud S, Arakji A, Eid A, Abd-Elrahman K, et al.
Clin Sci (Lond)
. 2021 Apr;
135(8):1015-1051.
PMID: 33881143
Antithrombotic drugs are widely used for primary and secondary prevention, as well as treatment of many cardiovascular disorders. Over the past few decades, major advances in the pharmacology of these...
20.
Hammoud S, AlZaim I, Mougharbil N, Koubar S, Eid A, Eid A, et al.
Biochem Pharmacol
. 2021 Mar;
186:114491.
PMID: 33647265
Diabetic nephropathy is a major health challenge with considerable economic burden and significant impact on patients' quality of life. Despite recent advances in diabetic patient care, current clinical practice guidelines...